Pharmaceutical industry

DDW Editor Reece Armstrong explores the rise of drug repurposing and the benefits and disadvantages it brings to drug discovery and development.  Drug repurposing, the act of finding new clinical targets for both approved and unapproved drugs, has emerged as a viable alternative to traditional drug discovery approaches.   It’s common knowledge that drug discovery […]

Roche and UK-based biopharmaceutical company PhoreMost have agreed to a multi-project target discovery collaboration. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. PhoreMost will deploy its phenotypic screening platform, SITESEEKER, toward disease-relevant pathways nominated by Roche. Novel targets identified will be further validated and […]